Better Buy in April: Aurora Cannabis Inc. (TSX:ACB) or Canopy Growth Corp. (TSX:WEED)?

Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) stock has outpaced Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) so far in 2019. Will this continue going forward.

| More on:
Business man on stock market financial trade indicator background.

Image source: Getty Images

In the beginning of 2019, I’d discussed whether cannabis stocks could provide the kind of spark growth investors were looking for. I’d concluded that the two stocks we will discuss today came at a nice price and were worth picking up. For a broader look, the Horizons Marijuana Life Sciences ETF (TSX:HMMJ) has climbed over 60% in 2019 as of close on March 21.

On the other hand, I have warned investors that cannabis stocks are riding high valuations right now. Those who want to load up on the sector should pick a better spot for an entry point. For those who want to pull the trigger sooner rather than later, today we are going to look at two top cannabis producers. Which is the better buy today? Let’s dive in.

Aurora Cannabis (TSX:ACB)(NYSE:ACB)

Aurora Cannabis stock has climbed 88.5% in 2019 as of close on March 21. Shares have surged 37% over the past month largely on the back of a hire that has generated considerable buzz. Its fiscal 2019 second-quarter results exceeded analysts’ expectations, but the market did not respond with much enthusiasm. As well, Aurora projects that its revenues will start to pick up in the second half of the fiscal year.

On March 13 the stock surged on news that billionaire investors Nelson Peltz had joined Aurora as a strategic advisor. He will receive stock options that could make him the company’s second-largest shareholder. Peltz is expected to facilitate deals with large consumer packaged-goods companies. Reports indicate that Aurora is looking to pair with multiple partners, which differentiates it from some of its top competitors.

Aurora boasted an RSI of 69 as of close on March 21, which puts it just outside of overbought territory. It is trading at the higher end of its 52-week range at writing.

Canopy Growth (TSX:WEED)(NYSE:CGC)

Canopy Growth stock has climbed 68% in 2019 so far. It had outpaced Aurora for much of 2019 before the report that Peltz had joined the Aurora team. The company mostly met expectations when it released its fiscal 2019 third-quarter results back in February. Canopy has been able to penetrate the recreational market more effectively than Aurora to kick things off, as recreational sales rose above medical cannabis revenue.

On March 21, Canopy Growth announced that it had acquired hemp company AgriNextUSA for an undisclosed sum. Canopy has generated some hype over its U.S. expansion in the hemp business, which should give it a nice footprint from which to operate when federal legalization arrives, hopefully sooner rather than later. The company plans to build a facility in New York called Hemp Industrial Park.

Beyond that, Canopy has managed to expand quickly into international markets and boasts a strong footprint in Europe. Shares hit overbought territory after a Canadian Imperial Bank of Commerce report gave it a boost in late January. As of this writing, Canopy has an RSI of 52, which puts it in neutral territory. However, shares are still trading at the higher end of its 52-week range.

Which is the better buy today?

As I mentioned at the beginning of this article, both stocks are pricey in late March. Ideally, investors should await a more attractive entry point, but Canopy continues to look like the surest bet. However, Aurora’s big hire may portend a big move down the pipe. Investors looking for the home run are better off scooping up Aurora.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan owns shares of Aurora Cannabis.

More on Investing

Tired or stressed businessman sitting on the walkway in panic digital stock market financial background
Stocks for Beginners

Buying These 2 Stocks Is a Good Way to Hedge Against a Falling Market

Investors looking to hedge against a stock downturn should consider these two stocks as viable long-term picks.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

How I’d Invest $1000 in February to Make Easy Passive Income

Looking to earn some extra passive income in February but don't have much cash? Build an easy portfolio with these…

Read more »

The sun sets behind a high voltage telecom tower.
Energy Stocks

2 Utilities Stocks With Sought-After Stability

Here's why Fortis and Hydro One are two top utilities stocks long-term investors may want to consider right now.

Read more »

clock time
Tech Stocks

3 Top ‘Future’ Stocks to Hold for the Rest of This Decade

Canadian growth stocks like Constellation Software are starting to look appealing.

Read more »

Coworkers standing near a wall
Investing

Is Restaurant Brands International Stock Worth Buying in February 2023?

After an impressive rally, does restaurant stock QSR have more room to grow, or is it already fairly valued?

Read more »

financial freedom sign
Investing

Millionaire by 40: Top 4 Ways to Hit Your 1st Million

Canadians who want to hit the millionaire milestone by the time they hit 40 may want to target growth stocks…

Read more »

Dollar symbol and Canadian flag on keyboard
Stocks for Beginners

2 Canadian Stocks I’ll Be Buying Hand Over Fist in 2023

There are some great Canadian stocks on sale right now. Here's a duo of companies I'm buying that you may…

Read more »

Women's fashion boutique Aritzia is a top stock to buy in September 2022.
Stocks for Beginners

Has ATZ Stock Bottomed Out?

Has ATZ stock finally bottomed out after losing nearly 10% of its value in 2022? Let’s find out.

Read more »